News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2017 Shelley Wood March 01, 2017
Presentation JIM 2017 Complete Cerebral Embolic Protection Utilizing TriGuard™ Presenter: Azeem Latib February 10, 2017
News Daily News NeuroARC Proposes New Standards for Assessing Neurologic Damage in CV Clinical Trials Caitlin E. Cox February 07, 2017